Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):159-61. doi: 10.1016/j.clon.2012.01.001. Epub 2012 Feb 7.

Authors

U Mallick, C Harmer, A Hackshaw, L Moss; IoN Trial Management Group

Collaborators

IoN Trial Management Group:
Ujjal Mallick, Sandy Beare, Carol Evans, Kate Farnell, Sharon Forsyth, Georgina Gerrard, Allan Hackshaw, Clive Harmer, Barney Harrison, Steve Hyer, Sarah J Johnson, Catherine Lemon, Val Lewington, Colin Lunt, Laura Moss, Kate Newbold, Alice Nicol, Chris Nutting, Nick Reed, Tim Stephenson, Jonathan Wadsley, John Watkinson, Beng Yap

PMID: 22316618
DOI: 10.1016/j.clon.2012.01.001

No abstract available

Publication types

Editorial

MeSH terms

Cell Differentiation
Humans
Iodine Radioisotopes / therapeutic use*
Multicenter Studies as Topic
Randomized Controlled Trials as Topic*
Risk Factors
Thyroid Neoplasms / pathology
Thyroid Neoplasms / radiotherapy*
Thyroidectomy
Thyrotropin / administration & dosage
United Kingdom

Substances

Iodine Radioisotopes
Thyrotropin